5Koike K,Kazuyuki M.Recent advances in the pathogenesis andmanagement of juvenile myelomonocytic leukemia.Br J Haematol,2008,141:567-575.
二级参考文献8
1Niemeyer CM, Fenu S, Hasle H, et al. Differentiating juvenile myelomonoc.ytic leukemia from infectious disease [J]. Blood, 1998, 91: 365-367.
2Koike K, Kazuyuki M. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia [J]. Br J Haematol, 2008,141 : 567-575.
3Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia(JMML) : results of the EWOG-MDS/ EBMT trial[J]. Blood, 2005, 105 : 410-419.
4Yoshimi A, Mohamed M, Bierings M, et al. Second allogeneic hematopoietic stem cell transplantation (HSCT) result in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia [ J ]. Leukemia, 2007,21 : 556-560.
5Faraci M, Micalizzi C, Lanino E, et al. Three consecutive related bone marrow transplants for juvenile myelomonocytic leukemia[J]. Pediatr Transplantation, 2005, 9: 797-800.
6Jaffe ES, Harris NL, Stein H, et al. World health organization classification on tumours:pathology and genetics of tumours of heamatopoietic and lymphoid tissues[J]. Lyon, 2001,213-276.
